Bob Huang, an analyst from Morgan Stanley, maintained the Sell rating on Lemonade (LMND – Research Report). The associated price target remains the same with $24.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Bob Huang has given his Sell rating due to a combination of factors impacting Lemonade’s financial outlook. While the company’s recent reinsurance renewal is a positive step, allowing Lemonade to retain a larger share of premiums, it also introduces increased exposure to potential losses. This heightened risk could lead to more volatile financial results, particularly in the event of catastrophic events.
Despite efforts to improve the combined ratio, Lemonade’s loss ratio remains high, indicating ongoing challenges in managing claims and expenses. The company’s ability to handle these risks effectively will be crucial in determining its future financial stability. As a result, Bob Huang advises caution, suggesting that the potential downsides outweigh the benefits of the current reinsurance strategy.
According to TipRanks, Huang is a 3-star analyst with an average return of 1.2% and a 60.42% success rate. Huang covers the Financial sector, focusing on stocks such as Progressive, Allstate, and Renaissancere Holdings.
In another report released today, KBW also reiterated a Sell rating on the stock with a $26.00 price target.